Prevention of Clinical and Histological Signs of Proteolipid Protein (Plp)-Induced Experimental Allergic Encephalomyelitis (EAE) in Mice by the Water-Soluble Carbon Monoxide-Releasing Molecule (CORM)-A1.
Clinical and Experimental Immunology(2011)
Abstract
We have evaluated the effects of the carbon monoxide-releasing molecule CORM-A1 [Na-2(BH3CO2); ALF421] on the development of relapsing-remitting experimental allergic encephalomyelitis (EAE) in SJL mice, an established model of multiple sclerosis (MS). The data show that the prolonged prophylactic administration of CORM-A1 improves the clinical and histopathological signs of EAE, as shown by a reduced cumulative score, shorter duration and a lower cumulative incidence of the disease as well as milder inflammatory infiltrations of the spinal cords. This study suggests that the use of CORM-A1 might represent a novel therapeutic strategy for the treatment of multiple sclerosis.
MoreTranslated text
Key words
animal models,carbon monoxide-releasing molecules,CORM-A1,experimental allergic encephalomyelitis,SJL mice
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined